219 E. 42nd St.,/Google maps
NEW YORK CITY—A joint venture Alexandria Real Estate Equities along with David Werner Real Estate, Deutsche Bank and the State of Wisconsin Investment Board purchased Pfizer Corporation's Manhattan headquarters at 219 E. 42nd St. and 235 E. 42nd St. for a total of $363.5 million, according to Real Capital Analytics. The deal is subject to a partial sale leaseback to Pfizer for at least five years. This gives Pfizer time to remain in its location, until its new space at the Spiral is completed. Tishman Speyer's 65-story skyscraper at 66 Hudson Blvd. is scheduled to open in 2022.
Alexandria released a statement that it is purchasing 219 E. 42nd St. from Pfizer for $203 million. The pharmaceutical company had made plans to sell both its E. 42nd streets in April, when it signed a lease to move its headquarters to the Spiral in Hudson Yards.
Recommended For You
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Betsy Kim
Betsy Kim was the bureau chief, East Coast, and New York City reporter for Real Estate Forum and GlobeSt.com. As a lawyer and journalist, Betsy has worked as the director of editorial and content for LexisNexis Lawyers.com, a TV/multi-media journalist for NBC and CBS affiliated TV stations in the Midwest, and an associate producer at Court TV.
